What Makes Scale-Up of Industrial Biotechnology so Difficult?
by Mark Warner (Warner Advisors LLC) Two questions have dominated the responses received after my Lessons Learned series on commercializing industrial biotechnology (here) and the deep-dive into the industrial biotechnology commercialization process (here), the questions are what makes scale-up of industrial